Celyad Oncology, a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell therapies, provides an update on its Celyad 2.0 business strategy which has been adopted and implemented over the last few months.
- Mon. Jun 5th, 2023
